# Androgenic Profile Following Controlled Ovarian Stimulation

> **NCT02992808** · PHASE4 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Infertility, Female

## Interventions

- **DRUG:** recombinant gonadotropins
- **DRUG:** HP-HMG

## Key facts

- **NCT ID:** NCT02992808
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2018-01
- **Final completion:** 2020-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02992808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02992808, "Androgenic Profile Following Controlled Ovarian Stimulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02992808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*